Harnessing placebo: Lessons from psychedelic science.
Chloé Pronovost-Morgan, Ido Hartogsohn, Johannes G. Ramaekers
Journal of Psychopharmacology June 30, 2023 DOI: 10.1177/02698811231182602 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Randomized Peer reviewed |
|---|---|
| Citations | 33 |
| Key points | Proposes a framework inspired by psychedelic science's "set and setting" concept to reintegrate nondrug variables into biomedicine and ethically harness placebo effects. |
Abstract
The randomized controlled trial (RCT) research design assumes that a drug's "specific" effect can be isolated, added, and subtracted from the "nonspecific" effect of context and person. While RCTs are helpful in assessing the added benefit of a novel drug, they tend to obscure the curative potential of extra-pharmacological variables, known as "the placebo effect." Ample empirical evidence suggests that person/context-dependent physical, social, and cultural variables not only add to, but also shape drug effects, making them worth harnessing for patient benefits. Nevertheless, utilizing placebo effects in medicine is challenging due to conceptual and normative obstacles. In this article, we propose a new framework inspired by the field of psychedelic science and its employment of the "set and setting" concept. This framework acknowledges that drug and nondrug factors have an interactive and synergistic relationship. From it, we suggest ways to reintegrate nondrug variables into the biomedical toolbox, to ethically harness the placebo effect for improved clinical care.
Citations in the library
Cited by 24
- Expectancy Effects in Psychedelic Trials. Biological Psychiatry: Cognitive Neuroscience and Neuroimaging May 1, 2024
- An international Delphi consensus for reporting of setting in psychedelic clinical trials. Nature Medicine June 3, 2025
- Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression American Journal of Psychiatry 2025
- A reflection on paradigmatic tensions within the FDA advisory committee for MDMA-assisted therapy. Journal of Psychopharmacology April 1, 2025
- Key competencies for psychedelic treatment in real-world mental health care settings. General Hospital Psychiatry 2025
and 19 more in the library
Cites 30
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Frontiers in Pharmacology January 17, 2018
- Psychedelics and the essential importance of context. Journal of Psychopharmacology February 15, 2018
- Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors Journal of Psychopharmacology October 11, 2017
- Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology Journal of Psychopharmacology November 16, 2016
and 25 more in the library